Skip to main content
Erschienen in: Comparative Hepatology 1/2005

Open Access 01.12.2005 | Case Report

Hypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture

verfasst von: António Sá Cunha, Jean-Frédéric Blanc, Hervé Trillaud, Victor De Ledinghen, Charles Balabaud, Paulette Bioulac-Sage

Erschienen in: Comparative Hepatology | Ausgabe 1/2005

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

The presence of a hypervascular nodule in a patient with cirrhosis is highly suggestive of a hepatocellular carcinoma.

Case presentation

A 55 year old man with idiopathic refractory anaemia was addressed for the cure of a recently appeared 3.3 cm hypervascular liver nodule. The nodule was not visible on the resected fresh specimen, but a paler zone was seen after formalin fixation. The surrounding liver was fibrotic (METAVIR score F3) and overloaded with iron. However, the paler zone, thought to be the nodule, had in fact a normal architecture, was less fibrotic, and contained some "portal tract-like structures" (but with arteries only); moreover, this paler area was devoid of iron, contained less glycogen and was characterized by foci of clear hepatocytes.

Conclusion

In spite of the absence of architectural distortion, and a normal proliferative index, the possibility of premalignancy or malignancy should be considered in this type of hypervascular and hyposiderotic nodule, occurring in the context of an iron overloaded liver.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1476-5926-4-5) contains supplementary material, which is available to authorized users.

Authors' contributions

A Sá Cunha performed the surgery. JF Blanc collected the references and contributed to the writing. H Trillaud reviewed the MRI. V De Ledinghen, hepatologist, was in charge of the patient. C Balabaud wrote the paper. P Bioulac-Sage interpreted the liver histology and contributed to the writing. All authors read and approved the final manuscript.
Abkürzungen
AFP
α-fetoprotein
ALAT
alanine aminotransferase
ASAT
aspartate aminotransferase
BMI
body-mass index
CRBP1
cellular retinol-binding protein 1
FNH
focal nodular hyperplasia
Hb
hemoglobin
Ht
hematocrit
HCC
hepatocellar carcinoma
MRI
magnetic resonance imaging
PAS
periodic acid Schiff
PT
protrombine time
RBC
red blood cells
α-SMA
α-smooth muscle actin
WBC
white blood cells.

Background

The presence of a hypervascular nodule in a patient with liver disease is highly suggestive of a hepatocellar carcinoma (HCC) [1]. Increased iron stores in patients with HCC developed on a non-cirrhotic liver is well documented [25]; iron stores are seldom depleted at the time of the discovery of the HCC [6]. Few cases of premalignant nodules associated with HCC have also been reported under these circumstances [7, 8]. In a fibrotic liver overloaded with iron, we report a case of a hypervascular and hyposiderotic nodule with premalignant features, but with a normal architecture.

Case presentation

General data

A 55 year old man with idiopathic refractory anaemia was addressed to our Unit for the cure of a recently appeared 3.3 cm hypervascular liver nodule in segment II (November, 2003). Physical examination was normal, including BMI. Liver function tests were as follows: ASAT = 53 IU/L (Normal = 40); ALAT = 58 IU/L (N = 50); Billirubin = 44 μmol/L (N = 17); PT = 70% (N = 70–100); V = 65% (N = 70–100); RBC = 2.9 × 106 cells/μl; Ht = 22.5% and Hb = 7.3 gm/dl; WBC = 4.6 × 103 cells/μl; and platelets = 210 × 109 /l. Ferritinemia was 1891 ng/l (N < 300), transferrin saturation was 100% (N < 40), iron concentration was 290 μmol/g (assessed by MRI, N < 36). AFP in blood was within the normal range. The patient, of Italian origin, was C282 Y -/-, H63D +/-, and S65C -/-, with no family history of iron overload. Markers for viral and autoimmune diseases were negative. Blood glucose was normal. He used to smoke 30 cigarettes per day; but had stopped for the last 8 years. He drank alcohol only occasionally. The treatment of his refractory anaemia consisted in blood transfusion (total of 10 packs), Desferoxamine, and Deferiprone.

Imaging results

Ultrasound examination showed a hypoechogenic ovoid nodule (3.2 × 1.9 cm) in segment II. MRI showed a hypointense non-tumoral liver on T1- and T2-weighted images due to iron overload. In comparison, the nodule was hyperintense on T1- and T2-weighted images. After gadolinium injection, the nodule was hyperintense on T1-weigthed images and remained so in the portal phase (Fig. 1).

Liver pathology

On December 2003, a left lobe hepatectomy was performed laparoscopically. Follow-up was uneventful. The resected specimen was carefully sliced but no nodule was found on the fresh specimen, and in the expected area. However, after formalin fixation, a 2 cm in diameter paler area was identified (Fig. 2, arrow). All slices were routinely processed. The following stainings were performed: H&E, trichrome, Perls, reticulin, PAS, and several immunostains (CD34, cytokeratins 7 and 19, CRBP1 and α-SMA; the latter for identification of quiescent and/or activated hepatic stellate cells [9]). The liver was fibrotic (METAVIR score F3) (Figs. 3a, 4a) with an iron overload 3 + (according to Searle score), mainly in hepatocytes of zones 1 and 2 (Fig. 5a). Liver iron concentration was 286 μmol/g (n < 36), and the iron concentration / age ratio was 5.1. Small foci of clear cells devoid of iron were also observed (not shown).
The paler zone, poorly limited from the adjacent parenchyma, was strikingly different. The architecture was preserved but the area was far less fibrotic (METAVIR score F1; Figs. 3b, 4b), with less iron (Fig. 5b), less glycogen (Fig. 6a), and with foci of clear hepatocytes (Figs. 6a, 6b). In these clear areas, hepatocytes were slightly bigger and occasionally displayed in two cell-thick plates. In these areas, as elsewhere, reticulin network, as well as Ki-67 (Mib-1) and CD34 were normal (not shown). One of the most striking findings was the presence of different types of portal tracts: some were normal (Fig. 7), whereas others contained mainly ductules (Fig. 8) and others arteries (Fig. 9). Regarding the number of CRBP1 and α-SMA positive cells, no obvious differences were seen between the fibrotic and non-fibrotic parts of the liver. CRBP 1 positive cells seemed to contain few lipid droplets.

Discussion

The mechanism accounting for the major hepatic iron overload is possibly multifactorial, including refractory sideroblastic anemia and blood transfusion, although the patient received only a limited number (<10) of blood transfusions. An associated hereditary iron overload such as transferrin receptor 2 haemochromatosis in this Italian patient cannot be ruled out.
Premalignant lesions have previously been described in iron overloaded patients in the absence of cirrhosis, although these lesions were discovered in the clinical context of a HCC [7, 8]. To our knowledge, this is the first reported case of a premalignant area mimicking by imaging a HCC, but exhibiting microscopically a still well-preserved architecture, in an otherwise fibrotic liver.
The hyperarterialized nodule did not correspond to a macroscopically visible nodule, but rather to an ill-defined area with preserved architectural organization. However, this area was considered as premalignant based on the following arguments: arterial hypervascularization with isolated arteries in the parenchyma [3]; loss of iron [10], and of glycogen; and presence of clear hepatocytes foci [11]. The diagnosis of a focal nodular hyperplasia (FNH)-like nodule as described in cirrhosis [1214], particularly related to alcohol, seems unlikely due to the loss of iron and to the presence of clear hepatocytes foci. Nonetheless, that diagnosis cannot be ruled out, and should always be kept in mind, especially if a liver transplantation is foreseen. Recently, it has been reported that coexisting iron overload could significantly worsen the course of FNH [15]. Unfortunately, and because no frozen material of the lesion (which was not visible) was available, in this case no specific molecular studies could be carried out to settle that important issue.
Our case strengthens previous observations [7, 8] showing that malignancy can overrun cirrhosis in iron overload (Fig. 10). A minor degree (stage) of fibrosis in areas devoid of iron could be a direct consequence of iron loss (less toxicity) and/or related to the malignant process [16, 17] in its early phase (as denoted by absence of cellular disorganization, and negativity of the MIB-1 immunostaining). It was concluded that this patient needs a strict surveillance because he may be at risk of recurrence. Indeed, clear hepatocytes foci devoid of iron were also observed outside the nodule [10].

Conclusion

The possibility of premalignancy or malignancy should be considered even in the absence of cirrhosis, when a nodule is observed in a patient with past or present liver iron overload.

Authors' contributions

A Sá Cunha performed the surgery. JF Blanc collected the references and contributed to the writing. H Trillaud reviewed the MRI. V De Ledinghen, hepatologist, was in charge of the patient. C Balabaud wrote the paper. P Bioulac-Sage interpreted the liver histology and contributed to the writing. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Taouli B, Losada M, Holland A, Krinsky G: Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology. 2004, 127: S144-52.PubMedCrossRef Taouli B, Losada M, Holland A, Krinsky G: Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology. 2004, 127: S144-52.PubMedCrossRef
2.
Zurück zum Zitat Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loreal O, Campion JP, Launois B, Ramee MP, Brissot P, Deugnier Y: Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology. 1995, 22: 446-450. 10.1016/0270-9139(95)90564-2.PubMed Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loreal O, Campion JP, Launois B, Ramee MP, Brissot P, Deugnier Y: Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology. 1995, 22: 446-450. 10.1016/0270-9139(95)90564-2.PubMed
3.
Zurück zum Zitat Kowdley KV: Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology. 2004, 127: S79-86.PubMedCrossRef Kowdley KV: Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology. 2004, 127: S79-86.PubMedCrossRef
4.
Zurück zum Zitat Bioulac-Sage P, Le Bail BL, Winnock M, Balabaud C, Bemard C, Blanc JF, Saric J: Occurrence of hepatocellular carcinoma in nonfibrotic livers. Hepatology. 2000, 32: 1411-1412.PubMedCrossRef Bioulac-Sage P, Le Bail BL, Winnock M, Balabaud C, Bemard C, Blanc JF, Saric J: Occurrence of hepatocellular carcinoma in nonfibrotic livers. Hepatology. 2000, 32: 1411-1412.PubMedCrossRef
5.
Zurück zum Zitat Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, Le Bail B, Carles J, Saric J, Balabaud C, Bioulac-Sage P: Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol. 2000, 32: 805-811. 10.1016/S0168-8278(00)80250-0.PubMedCrossRef Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, Le Bail B, Carles J, Saric J, Balabaud C, Bioulac-Sage P: Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol. 2000, 32: 805-811. 10.1016/S0168-8278(00)80250-0.PubMedCrossRef
6.
Zurück zum Zitat Pellise M, Gonzalez-Abraldes J, Navasa M, Miquel R, Bruguera M: [Hepatocellular carcinoma in a patient with hereditary hemochromatosis without cirrhosis]. Gastroenterol Hepatol. 2001, 24: 132-134.PubMedCrossRef Pellise M, Gonzalez-Abraldes J, Navasa M, Miquel R, Bruguera M: [Hepatocellular carcinoma in a patient with hereditary hemochromatosis without cirrhosis]. Gastroenterol Hepatol. 2001, 24: 132-134.PubMedCrossRef
7.
Zurück zum Zitat Blanc JF, De Ledinghen V, Trimoulet P, Le Bail B, Bernard PH, Saric J, Balabaud C, Bioulac-Sage P: Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation. J Hepatol. 1999, 30: 325-329. 10.1016/S0168-8278(99)80080-4.PubMedCrossRef Blanc JF, De Ledinghen V, Trimoulet P, Le Bail B, Bernard PH, Saric J, Balabaud C, Bioulac-Sage P: Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation. J Hepatol. 1999, 30: 325-329. 10.1016/S0168-8278(99)80080-4.PubMedCrossRef
8.
Zurück zum Zitat Attia A, Blanc JF, Saric J, Balabaud C, Bioulac-Sage P: [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron]. Gastroenterol Clin Biol. 2000, 24: 955-959.PubMed Attia A, Blanc JF, Saric J, Balabaud C, Bioulac-Sage P: [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron]. Gastroenterol Clin Biol. 2000, 24: 955-959.PubMed
9.
Zurück zum Zitat Lepreux S, Bioulac-Sage P, Gabbiani G, Sapin V, Housset C, Rosenbaum J, Balabaud C, Desmouliere A: Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations. J Hepatol. 2004, 40: 774-780. 10.1016/j.jhep.2004.01.008.PubMedCrossRef Lepreux S, Bioulac-Sage P, Gabbiani G, Sapin V, Housset C, Rosenbaum J, Balabaud C, Desmouliere A: Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations. J Hepatol. 2004, 40: 774-780. 10.1016/j.jhep.2004.01.008.PubMedCrossRef
10.
Zurück zum Zitat Deugnier YM, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, Powell LW, Halliday JW: Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology. 1993, 18: 1363-1369. 10.1016/0270-9139(93)90225-C.PubMed Deugnier YM, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, Powell LW, Halliday JW: Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology. 1993, 18: 1363-1369. 10.1016/0270-9139(93)90225-C.PubMed
11.
Zurück zum Zitat Su Q, Bannasch P: Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol. 2003, 31: 126-133. 10.1080/01926230309732.PubMedCrossRef Su Q, Bannasch P: Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol. 2003, 31: 126-133. 10.1080/01926230309732.PubMedCrossRef
12.
Zurück zum Zitat Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, Desmet V, Roskams T: Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl. 2002, 8: 749-761. 10.1053/jlts.2002.34922.PubMedCrossRef Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, Desmet V, Roskams T: Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl. 2002, 8: 749-761. 10.1053/jlts.2002.34922.PubMedCrossRef
13.
Zurück zum Zitat Nakashima O, Kurogi M, Yamaguchi R, Miyaaki H, Fujimoto M, Yano H, Kumabe T, Hayabuchi N, Hisatomi J, Sata M, Kojiro M: Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules?. J Hepatol. 2004, 41: 992-998. 10.1016/j.jhep.2004.08.014.PubMedCrossRef Nakashima O, Kurogi M, Yamaguchi R, Miyaaki H, Fujimoto M, Yano H, Kumabe T, Hayabuchi N, Hisatomi J, Sata M, Kojiro M: Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules?. J Hepatol. 2004, 41: 992-998. 10.1016/j.jhep.2004.08.014.PubMedCrossRef
14.
Zurück zum Zitat Quaglia A, Tibballs J, Grasso A, Prasad N, Nozza P, Davies SE, Burroughs AK, Watkinson A, Dhillon AP: Focal nodular hyperplasia-like areas in cirrhosis. Histopathology. 2003, 42: 14-21. 10.1046/j.1365-2559.2003.01550.x.PubMedCrossRef Quaglia A, Tibballs J, Grasso A, Prasad N, Nozza P, Davies SE, Burroughs AK, Watkinson A, Dhillon AP: Focal nodular hyperplasia-like areas in cirrhosis. Histopathology. 2003, 42: 14-21. 10.1046/j.1365-2559.2003.01550.x.PubMedCrossRef
15.
Zurück zum Zitat Hohler T, Lohse AW, Schirmacher P: Progressive focal nodular hyperplasia of the liver in a patient with genetic hemochromatosis--growth promotion by iron overload?. Dig Dis Sci. 2000, 45: 587-590. 10.1023/A:1005413728101.PubMedCrossRef Hohler T, Lohse AW, Schirmacher P: Progressive focal nodular hyperplasia of the liver in a patient with genetic hemochromatosis--growth promotion by iron overload?. Dig Dis Sci. 2000, 45: 587-590. 10.1023/A:1005413728101.PubMedCrossRef
16.
Zurück zum Zitat Theise ND, Lapook JD, Thung SN: A macroregenerative nodule containing multiple foci of hepatocellular carcinoma in a noncirrhotic liver. Hepatology. 1993, 17: 993-996. 10.1016/0270-9139(93)90112-Z.PubMedCrossRef Theise ND, Lapook JD, Thung SN: A macroregenerative nodule containing multiple foci of hepatocellular carcinoma in a noncirrhotic liver. Hepatology. 1993, 17: 993-996. 10.1016/0270-9139(93)90112-Z.PubMedCrossRef
17.
Zurück zum Zitat Park YN, Yang CP, Cubukcu O, Thung SN, Theise ND: Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. Liver. 1997, 17: 271-274.PubMedCrossRef Park YN, Yang CP, Cubukcu O, Thung SN, Theise ND: Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. Liver. 1997, 17: 271-274.PubMedCrossRef
Metadaten
Titel
Hypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture
verfasst von
António Sá Cunha
Jean-Frédéric Blanc
Hervé Trillaud
Victor De Ledinghen
Charles Balabaud
Paulette Bioulac-Sage
Publikationsdatum
01.12.2005
Verlag
BioMed Central
Erschienen in
Comparative Hepatology / Ausgabe 1/2005
Elektronische ISSN: 1476-5926
DOI
https://doi.org/10.1186/1476-5926-4-5

Weitere Artikel der Ausgabe 1/2005

Comparative Hepatology 1/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.